Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.

Stojanovski BM, Hunter GA, Na I, Uversky VN, Jiang RHY, Ferreira GC.

Mol Genet Metab. 2019 Jun 13. pii: S1096-7192(19)30228-8. doi: 10.1016/j.ymgme.2019.06.003. [Epub ahead of print] Review.

PMID:
31345668
2.

Cytotoxic Effects of Rabbit Anti-Thymocyte Globulin preparations on Primary Human Thymic Epithelial Cells.

Kaebisch EM, Cho MY, Oh YS, Olfe LI, Szyska M, Becker SC, Reinke P, Volk HD, Gillissen B, Bullinger L, Thiel A, Na IK.

Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002799. [Epub ahead of print]

PMID:
31205263
3.

Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY.

Kretschmann S, Herda S, Bruns H, Russ J, van der Meijden ED, Schlötzer-Schrehardt U, Griffioen M, Na IK, Mackensen A, Kremer AN.

J Clin Invest. 2019 Jun 17;129(7):2952-2963. doi: 10.1172/JCI123105. eCollection 2019 Jun 17.

4.

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.

Na IK, Buckland M, Agostini C, Edgar JDM, Friman V, Michallet M, Sánchez-Ramón S, Scheibenbogen C, Quinti I.

Eur J Haematol. 2019 Jun;102(6):447-456. doi: 10.1111/ejh.13223. Epub 2019 Mar 24.

PMID:
30801785
5.

Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.

Tsai JJ, Velardi E, Shono Y, Argyropoulos KV, Holland AM, Smith OM, Yim NL, Rao UK, Kreines FM, Lieberman SR, Young LF, Lazrak A, Youssef S, Fu YY, Liu C, Lezcano C, Murphy GF, Na IK, Jenq RR, Hanash AM, Dudakov JA, van den Brink MRM.

Blood. 2018 Dec 27;132(26):2763-2774. doi: 10.1182/blood-2017-10-812941. Epub 2018 Oct 31.

PMID:
30381375
6.

Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.

Na I, Catena D, Kong MJ, Ferreira GC, Uversky VN.

Int J Mol Sci. 2018 Jun 28;19(7). pii: E1899. doi: 10.3390/ijms19071899.

7.

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma.

Kim SY, Myung JK, Kim HR, Na II, Koh JS, Baek HJ, Kim CH.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):62-70. doi: 10.4046/trd.2018.0004. Epub 2018 Jun 19.

8.

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C.

Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

PMID:
29632329
9.

A comparative analysis of human bone marrow-resident and peripheral memory B cells.

Becker SC, Szyska M, Mensen A, Hellwig K, Otto R, Olfe L, Volk HD, Dörner T, Dörken B, Scheibenbogen C, Schröder J, Hocke AC, Na IK.

J Allergy Clin Immunol. 2018 May;141(5):1911-1913.e7. doi: 10.1016/j.jaci.2017.12.983. Epub 2018 Jan 31. No abstract available.

PMID:
29355676
10.

A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells In Vivo.

Szyska M, Herda S, Althoff S, Heimann A, Russ J, D'Abundo D, Dang TM, Durieux I, Dörken B, Blankenstein T, Na IK.

Cancer Immunol Res. 2018 Jan;6(1):110-120. doi: 10.1158/2326-6066.CIR-17-0256. Epub 2017 Dec 19.

11.

Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children.

Kim J, Lee BS, Kim B, Na I, Lee J, Lee JY, Park MR, Kim H, Sohn I, Ahn K.

Benef Microbes. 2017 Oct 13;8(5):755-761. doi: 10.3920/BM2017.0034.

PMID:
29035111
12.

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.

Kim HR, Kim SY, Kim CH, Yang SH, Lee JC, Choi CM, Na II.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2283-2290. doi: 10.1007/s00432-017-2473-8. Epub 2017 Jul 8.

PMID:
28689332
13.

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer.

Kim SY, Kim HR, Kim CH, Koh JS, Baek HJ, Choi CM, Song JS, Lee JC, Na II.

Ann Thorac Med. 2017 Jan-Mar;12(1):36-41. doi: 10.4103/1817-1737.197774.

14.

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.

Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ.

Cancer Res Treat. 2017 Jul;49(3):807-815. doi: 10.4143/crt.2016.326. Epub 2017 Jan 18.

15.

Molecular dynamics analysis of the structural and dynamic properties of the functionally enhanced hepta-variant of mouse 5-aminolevulinate synthase.

Na I, DeForte S, Stojanovski BM, Ferreira GC, Uversky VN.

J Biomol Struct Dyn. 2018 Jan;36(1):152-165. doi: 10.1080/07391102.2016.1269688. Epub 2017 Jan 9.

PMID:
27928941
16.

Highly Disordered Proteins in Prostate Cancer.

Uversky VN, Na I, Landau KS, Schenck RO.

Curr Protein Pept Sci. 2017;18(5):453-481. doi: 10.2174/1389203717666161028145848. Review.

PMID:
27804860
17.

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.

Hemmati PG, Vuong LG, Terwey TH, Jehn CF, le Coutre P, Penack O, Na IK, Dörken B, Arnold R.

Eur J Haematol. 2017 Feb;98(2):160-168. doi: 10.1111/ejh.12815. Epub 2016 Oct 22.

PMID:
27706846
18.

Effect of natural polymorphism on structure and function of the Yersinia pestis outer membrane porin F (OmpF protein): a computational study.

Shaban H, Na I, Kislichkina AA, Dentovskaya SV, Anisimov AP, Uversky VN.

J Biomol Struct Dyn. 2017 Sep;35(12):2588-2603. doi: 10.1080/07391102.2016.1224734. Epub 2016 Sep 3.

PMID:
27593697
19.

Unfoldomics of prostate cancer: on the abundance and roles of intrinsically disordered proteins in prostate cancer.

Landau KS, Na I, Schenck RO, Uversky VN.

Asian J Androl. 2016 Sep-Oct;18(5):662-72. doi: 10.4103/1008-682X.184999.

20.

Corrigendum: Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.

Lee JY, Park YK, Chung ES, Na IY, Ko KS.

Sci Rep. 2016 Jul 25;6:30365. doi: 10.1038/srep30365. No abstract available.

21.

Autophagy-related intrinsically disordered proteins in intra-nuclear compartments.

Na I, Meng F, Kurgan L, Uversky VN.

Mol Biosyst. 2016 Aug 16;12(9):2798-817. doi: 10.1039/c6mb00069j.

PMID:
27377881
22.

Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.

Lee JY, Park YK, Chung ES, Na IY, Ko KS.

Sci Rep. 2016 May 6;6:25543. doi: 10.1038/srep25543. Erratum in: Sci Rep. 2016 Jul 25;6:30365.

23.

Troponins, intrinsic disorder, and cardiomyopathy.

Na I, Kong MJ, Straight S, Pinto JR, Uversky VN.

Biol Chem. 2016 Aug 1;397(8):731-51. doi: 10.1515/hsz-2015-0303.

PMID:
27074551
24.

Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.

Shin DY, Lee DH, Kim CH, Koh JS, Lee JC, Baek HJ, Kim SW, Choi CM, Na II.

J Cancer Res Ther. 2016 Jan-Mar;12(1):318-22. doi: 10.4103/0973-1482.154024.

25.

Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Szyska M, Na IK.

Front Immunol. 2016 Mar 30;7:118. doi: 10.3389/fimmu.2016.00118. eCollection 2016. Review.

26.

Compartmentalization and Functionality of Nuclear Disorder: Intrinsic Disorder and Protein-Protein Interactions in Intra-Nuclear Compartments.

Meng F, Na I, Kurgan L, Uversky VN.

Int J Mol Sci. 2015 Dec 25;17(1). pii: E24. doi: 10.3390/ijms17010024.

27.

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP.

Shin DY, Kim A, Byun BH, Moon H, Kim S, Ko YJ, Kim MJ, Lee HR, Kang HJ, Na II, Park S, Lee SS, Yang SH.

Ann Hematol. 2016 Feb;95(3):409-16. doi: 10.1007/s00277-015-2571-0. Epub 2015 Dec 10.

PMID:
26658607
28.

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.

Shin DY, Choi YH, Lee HR, Na II, Yuh YJ, Kim BS, Chung IJ, Bae WK, Shim HJ, Song EK, Yang SH, Kang HJ.

Cancer Chemother Pharmacol. 2016 Jan;77(1):163-8. doi: 10.1007/s00280-015-2904-7. Epub 2015 Nov 20.

PMID:
26589790
29.

Comparison of the Virulence-Associated Phenotypes of Five Species of Acinetobacter baumannii Complex.

Na IY, Chung ES, Jung CY, Kim DH, Shin J, Kang K, Kim ST, Ko KS.

J Microbiol Biotechnol. 2016 Jan;26(1):171-9. doi: 10.4014/jmb.1507.07076.

30.

Emerging Role of Tyrosine Kinases as Drugable Targets in Cancer.

Na IK, le Coutre P.

Biomark Insights. 2015 Sep 10;10(Suppl 3):29-31. doi: 10.4137/BMI.S22432. eCollection 2015.

31.

Altered B-cell subsets and functional B-cell defects in selective IgM deficiency.

Mensen A, Krause T, Hanitsch LG, Meisel C, Kleint ME, Volk HD, Na IK, Scheibenbogen C.

Clin Immunol. 2015 Dec;161(2):96-102. doi: 10.1016/j.clim.2015.08.017. Epub 2015 Sep 3.

PMID:
26342539
32.

Apoptosis Susceptibility Prolongs the Lack of Memory B Cells in Acute Leukemic Patients After Allogeneic Hematopoietic Stem Cell Transplantation.

Mensen A, Oh Y, Becker SC, Hemmati PG, Jehn C, Westermann J, Szyska M, Göldner H, Dörken B, Scheibenbogen C, Arnold R, Na IK.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1895-906. doi: 10.1016/j.bbmt.2015.08.008. Epub 2015 Aug 10.

33.

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.

Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, Du J, Blazar BR, Arnold R, Kröger N, Passweg J, Halter J, Socié G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N.

Leukemia. 2015 Oct;29(10):2062-8. doi: 10.1038/leu.2015.212. Epub 2015 Jul 31.

34.

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.

Shin DY, Lee HR, Kang HJ, Na II, Chang YH, Yang SH.

Blood Res. 2015 Jun;50(2):114-7. doi: 10.5045/br.2015.50.2.114. Epub 2015 Jun 25. No abstract available.

35.

Soft, curved electrode systems capable of integration on the auricle as a persistent brain-computer interface.

Norton JJ, Lee DS, Lee JW, Lee W, Kwon O, Won P, Jung SY, Cheng H, Jeong JW, Akce A, Umunna S, Na I, Kwon YH, Wang XQ, Liu Z, Paik U, Huang Y, Bretl T, Yeo WH, Rogers JA.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):3920-5. doi: 10.1073/pnas.1424875112. Epub 2015 Mar 16.

36.

pspK gene prevalence and characterization of non-typable Streptococcus pneumonia isolates from Asian countries.

Na IY, Baek JY, Park IH, Kim DH, Song JH, Ko KS.

Microbiology. 2015 May;161(Pt 5):973-9. doi: 10.1099/mic.0.000073. Epub 2015 Mar 6.

PMID:
25750083
37.

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.

Hemmati PG, Terwey TH, Na IK, Jehn CF, le Coutre P, Vuong LG, Dörken B, Arnold R.

Eur J Haematol. 2015 Dec;95(6):498-506. doi: 10.1111/ejh.12522. Epub 2015 Mar 24.

PMID:
25598394
38.

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.

Hemmati PG, Terwey TH, Na IK, le Coutre P, Jehn CF, Vuong LG, Dörken B, Arnold R.

Eur J Haematol. 2015 May;94(5):431-8. doi: 10.1111/ejh.12449. Epub 2014 Oct 11.

PMID:
25220715
39.

Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma.

Shin DY, Kim S, Park S, Koh JS, Kim CH, Baek H, Yang SH, Na II.

Endocr Relat Cancer. 2014 Oct;21(5):715-21. doi: 10.1530/ERC-14-0259. Epub 2014 Jul 16.

PMID:
25030993
40.

Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.

Lee JY, Chung ES, Na IY, Kim H, Shin D, Ko KS.

J Antimicrob Chemother. 2014 Nov;69(11):2966-71. doi: 10.1093/jac/dku238. Epub 2014 Jul 2.

PMID:
24994873
41.

Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.

Mensen A, Na IK, Häfer R, Meerbach A, Schlecht M, Pietschmann ML, Gruhn B.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1971-80. doi: 10.1007/s00432-014-1742-z. Epub 2014 Jun 25.

PMID:
24962343
42.

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer.

Hwang JP, Lim I, Na II, Cho EH, Kim BI, Choi CW, Lim SM.

Nucl Med Mol Imaging. 2014 Jun;48(2):114-20. doi: 10.1007/s13139-013-0255-z. Epub 2013 Dec 6.

43.

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Mensen A, Jöhrens K, Anagnostopoulos I, Demski S, Oey M, Stroux A, Hemmati P, Westermann J, Blau O, Wittenbecher F, Movassaghi K, Szyska M, Thomas S, Dörken B, Scheibenbogen C, Arnold R, Na IK.

Blood. 2014 Aug 7;124(6):963-72. doi: 10.1182/blood-2013-11-539031. Epub 2014 May 15.

PMID:
24833353
44.

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer.

Kim S, Ko Y, Kwon S, Shin DY, Kim CH, Yang SH, Cho SJ, Na II.

Psychooncology. 2014 Nov;23(11):1300-6. doi: 10.1002/pon.3565. Epub 2014 May 12.

PMID:
24816481
45.

Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome.

Choi HS, Kim MJ, Moon CH, Yoon JH, Ku HR, Kang GW, Na II, Lee SS, Lee BC, Park YJ, Kim HI, Ku YH.

Endocrinol Metab (Seoul). 2014 Mar;29(1):96-100. doi: 10.3803/EnM.2014.29.1.96. Epub 2014 Mar 14.

46.

Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing.

Hattori Y, Falgout L, Lee W, Jung SY, Poon E, Lee JW, Na I, Geisler A, Sadhwani D, Zhang Y, Su Y, Wang X, Liu Z, Xia J, Cheng H, Webb RC, Bonifas AP, Won P, Jeong JW, Jang KI, Song YM, Nardone B, Nodzenski M, Fan JA, Huang Y, West DP, Paller AS, Alam M, Yeo WH, Rogers JA.

Adv Healthc Mater. 2014 Oct;3(10):1597-607. doi: 10.1002/adhm.201400073. Epub 2014 Mar 26.

47.

A putative role of the Sup35p C-terminal domain in the cytoskeleton organization during yeast mitosis.

Na I, Reddy KD, Breydo L, Xue B, Uversky VN.

Mol Biosyst. 2014 Apr;10(4):925-40. doi: 10.1039/c3mb70515c. Epub 2014 Feb 19.

PMID:
24549315
48.

Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.

Lee JY, Na IY, Park YK, Ko KS.

J Antimicrob Chemother. 2014 May;69(5):1248-56. doi: 10.1093/jac/dkt531. Epub 2014 Jan 27.

PMID:
24474431
49.

EGFR mutation and brain metastasis in pulmonary adenocarcinomas.

Shin DY, Na II, Kim CH, Park S, Baek H, Yang SH.

J Thorac Oncol. 2014 Feb;9(2):195-9. doi: 10.1097/JTO.0000000000000069.

50.

Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Lee JY, Na II, Jang SH, Hwang YI, Choe du H, Kim CH, Baek H.

J Thorac Dis. 2013 Dec;5(6):758-63. doi: 10.3978/j.issn.2072-1439.2013.11.24.

Supplemental Content

Support Center